Commentary: an aye for eye gene therapy

scientific article published in February 2006

Commentary: an aye for eye gene therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/HUM.2006.17.177
P698PubMed publication ID16454651
P5875ResearchGate publication ID7318852

P2093author name stringJean Bennett
P433issue2
P921main subjectgene therapyQ213901
P1104number of pages3
P304page(s)177-179
P577publication date2006-02-01
P1433published inHuman Gene TherapyQ15757580
P1476titleCommentary: an aye for eye gene therapy
P478volume17

Reverse relations

cites work (P2860)
Q36708300AAV-mediated gene transfer for retinal diseases
Q33397385Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.
Q35594134Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.
Q37731899Drug and gene delivery to the back of the eye: from bench to bedside.
Q33267297Efficient non-viral ocular gene transfer with compacted DNA nanoparticles
Q36099346Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors
Q44953303Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
Q36545533Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.
Q42019986Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria
Q36965152Versatility of AAV vectors for retinal gene transfer
Q84748042WITHDRAWN: Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria

Search more.